NORTH Trial Web Site Terms of Use

Introduction
Welcome to the NORTH Clinical Trial web site. This web site is owned and operated by ImmunoGen, Inc., a biotechnology company located in Waltham, Massachusetts, that develops potential treatments for cancer.

Please carefully read this Policy. You may use this web site, provided you agree to follow and be bound by these terms and conditions. If you do not agree, you must exit this web site now. Additionally, please note that we may revise these terms at any time without notice by updating the Usage Policy posted on this web site. Your use of this web site following any such changes constitutes your agreement to follow and be bound by the terms and conditions as changed, and thus, you should periodically visit this page to review the terms that apply to your use of our web site at that time.

Protection of Content
All content of this web site is protected by copyright. Thus, you may not download material from this web site for any purpose other than for your personal reference without our prior written consent.

Nothing contained in our web site should be construed as granting any license or right to use any trademark or logo that appears on this web site.

Third Party Links
This web site includes links to other web sites. We provide these links as a convenience for you, and our inclusion of a link does not imply an endorsement of that web site. We do not take any responsibility or assume any liability for information contained on third party web sites. You use the links to those web sites at your own risk, and you are responsible for learning about and complying with the terms of usage and other conditions posted on those web sites.

Medical Information
Nothing on this web site is a substitute for professional medical assessment, consultation or treatment, and none of the information contained on this web site should be construed as providing medical advice or services.

Trial Information
There is no guarantee that the list of participating clinical trial sites on this web site is current and/or comprehensive, or that you will qualify for participation in the NORTH trial.

Disclaimer
Your use of this web site and the information it contains is at your own risk. Neither ImmunoGen nor any party involved in creating or delivering this web site shall be liable for damages of any kind that may result from access to, or use of the information contained on, this web site, including, but not limited to, damages arising from content errors, omissions, tampering by outside parties, out-of-date information, factual inaccuracies, or equipment damage to your computer from viruses or downloading of software through this website.

IMMUNOGEN MAKES NO REPRESENTATIONS OR WARRANTIES, EXPRESS OR IMPLIED, WITH RESPECT TO THE USE OF THIS WEB SITE OR ANY INFORMATION OR SERVICES OBTAINED THROUGH THIS WEB SITE. IN NO EVENT WILL IMMUNOGEN BE LIABLE FOR ANY LOSSES OR DAMAGES OF ANY KIND RESULTING DIRECTLY OR INDIRECTLY FROM ANY USE OF THIS WEB SITE OR DEFECT IN THIS WEB SITE OR IN ANY INFORMATION CONTAINED IN THIS WEB SITE.

By using this web site, you assume the risk that the information and materials on this web site may be incomplete, inaccurate, out-of-date, or may not meet your needs or requirements.

Please note that some jurisdictions may not allow the exclusion of implied warranties, so some of the above exclusions may not apply to you. Check your local laws for any restrictions or limitations regarding the exclusion of implied warranties.

Governing Law and Jurisdiction
This web site is operated by ImmunoGen, Inc. from within the United States. Any claims relating to, and the use of, this web site are governed by the laws of the Commonwealth of Massachusetts. By using this web site, you consent to personal jurisdiction in the federal and state courts of Massachusetts, which shall have exclusive jurisdiction for any action arising out of or relating to this web site or your use of this web site.

 

If you have any questions about the rights and restrictions above, please contact info@immunogen.com.